This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Advanced Practice Nurse and Physician Assistant IBD Immersion: An IBD-U™  Initiative

Advanced Practice Nurse and Physician Assistant IBD Immersion: An IBD-U™ Initiative

Format

Slide Lecture Series

Time to Complete

1.50 hours

Released

February 20, 2017

Expires

February 19, 2018
Add to Queue


Maximum Credits

1.50 / AAPA Category 1 CME Credits
1.50 / ANCC Contact Hours
1.50 / AANP Contact Hours (0.50 pharmacology hours)

Accredited Provider


This continuing education activity is provided by Vindico Medical Education.

Commercial Supporter

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

There is no non-commercial support for this activity.

Program Description

The incidence and prevalence of inflammatory bowel disease (IBD) continues to rise worldwide. In the United States, it is estimated that 1.6 million people are affected by Crohn's disease or ulcerative colitis, the two main subtypes of IBD, and each year an additional 70,000 new cases of IBD will be diagnosed. The continuing advancement of diagnostic and therapeutic options for IBD have the potential to impact clinical outcomes as well as patient quality of life. It is important that healthcare professionals caring for patients with IBD keep current with standard of care and emerging management strategies. In this CME activity, Dr. Russell D. Cohen and Dr. David T. Rubin of the IBD Center at the University of Chicago Medicine discuss clinical features and diagnostic testing of IBD, current standards of care, and emerging treatment options.

Intended Audience

The intended audience for the activity is gastroenterology nurses, nurse practitioners, physician assistants, and other healthcare professionals involved in the treatment of patients with IBD.

Purpose/Educational Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Examine the pathophysiology of inflammatory bowel disease to better understand how specific therapies aid in the treatment of mild-to-severe disease
  • Describe diagnostic modalities and assessment tools that may improve the early diagnosis of inflammatory bowel disease
  • Evaluate medical advances for patients with inflammatory bowel disease that may improve patient management and outcomes

Conflict Of Interest Disclosure Policy

In accordance with the Accreditation Council for Continuing Medical Education and the American Nurses Credentialing Center’s Standards for Commercial Support, all CME/CE providers are required to disclose to the activity audience the relevant financial relationship of the planners, teachers, and authors involved in the development of CME/CE content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME/CE activity content over which the individual has control. Relationship information appears below.

Faculty

Activity Co-Chairs:
Russell D. Cohen, MD, FACG, AGAF
Professor of Medicine, Pritzker School of Medicine
Director, Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL

Dr. Cohen discloses the following:
Consulting Fee: AbbVie Laboratories, Celgene, Entera Health, Hospira, Janssen (Johnson & Johnson / Centocor), Pfizer, Sandoz Biopharmaceuticals, Takeda, UCB Pharma
Contracted Research: AstraZeneca, Celgene, Gilead Sciences, Medimmune, Mesoblast Ltd., Osiris Therapeutics, Pfizer, Receptos, RedHill Biopharma, Sanofi-Aventis, UCB Pharma

David T. Rubin, MD, FACG, AGAF, FACP, FASGE
Joseph B. Kirsner Professor of Medicine
Section Chief, Gastroenterology, Hepatology and Nutrition
Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL

Dr. Rubin discloses the following:
Consulting Fee: AbbVie, Amgen, Emmi, Genentech, Janssen, Pfizer, Shire, Takeda, UCB Pharma
Contracted Research: AbbVie, Amgen, Genentech, Janssen, Prometheus, Shire, Takeda, UCB Pharma
Board of Trustees: American College of Gastroenterology; Co-Founder: Cornerstones Health, Inc., GoDuRn, LLC

Mary Ayers, BSN-RN, discloses the following:
Speakers Bureau: AbbVie

Ashley A. Bochenek, APN, FNP-BC, discloses the following:
Consulting Fee: Takeda
Speakers Bureau: AbbVie, Janssen

Janice C. Colwell, APRN, CWOCN, FAAN, discloses the following:
Speakers Bureau: Coloplast, Hollister

Michele Rubin, MSN,APN,CNS,CGRN, has no relevant financial relationships to disclose.

Reviewer reports the following relationships:
Linda A. Giarraputo, PA-C
, has no relevant financial relationships to disclose.

Nurse Planners report the following relationships:
Barbara A. Niedz, PhD, RN, CPHQ
, has no relevant financial relationships to disclose.

Natalie Wilson, MS, RN, has no relevant financial relationships to disclose.

Accredited Provider Disclosure

Vindico staff has no relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Credit

1.50

Type

AAPA Category I CME credit

Accreditation Statement

This program was planned in accordance with AAPA's CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.

Designation Statement

This program has been reviewed and is approved for a maximum of 1.50 AAPA Category 1 CME credits by the PA Review Panel. Approval is valid for one year from the issue date of 12/30/2016. Participants may submit the post-test at any time during that period.

Credit

1.50

Type

CE for Nurses

Accreditation Statement

Vindico Medical Education, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC’s) Commission on Accreditation.

Designation Statement

Vindico Medical Education will provide 1.50 contact hours for nurses. This continuing educational activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A, Inc.

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.

Credit

1.50

Type

CE for Nurse Practitioners

Accreditation Statement

This activity was planned in accordance with AANP CE Standards and Policies.

Designation Statement

This activity is approved for 1.50 contact hour(s) of continuing education (which includes 0.50 hours of pharmacology). Activity ID 16112444.

Disclosure of Unlabeled Use

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Instructions

To participate in this CME/CE activity, you must read the objectives, answer the pre-test, review the content, and complete the post-test and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 3 post-test questions correctly. Upon receipt of the completed materials, if a satisfactory score on the post-test is achieved, myCME will issue a credit certificate.

If you have CME Questions, please contact Vindico at cme@vindicoCME.com.

Privacy Policy

Copyright

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2017 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue